Enalapril Maleate Tablets
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Yes — there is an active recall. 5 ongoing FDA recalls mention Enalapril (22 total). Check the affected lots below.
Most common reason: Impurity / degradation (11 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Enalapril. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.
Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.
Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.
Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.
Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.
Failed Impurities/Degradation Specification; out-of-specification results for the Enalapril DKT degradant
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.
Failed Stability Specifications
Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.
Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset
Labeling Illegible: Some bottles labels have incomplete NDC numbers and missing strength.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.